› › › Pfizer, Inc.
Les meilleurs offres pour accéder les cours en temps réel en illimité
Expert
Abonnement Mensuel
Seulement
92,39 €
Pro
Abonnement Mensuel
Seulement
52,79 €
Real-time Level 1 for Canada + USA
Abonnement Mensuel
Seulement
32,99 €
Prix hors taxes

Actualités Pfizer - PFE

Nom Action Symbole Action Marché Type ISIN Description Action
Pfizer, Inc. PFE NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Plus Haut Plus Bas Ouverture Clôture Veille Dernier échange
  -1,06 -2,36% 43,92 44,944 43,675 44,82 44,98 06:05:47
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/12/201817:17DJNToday's Logistics Report: Scrambling for Storage;..
07/12/201812:46EDGARCurrent Report Filing (8-k)
04/12/201813:16EDGARStatement of Changes in Beneficial Ownership (4)
04/12/201813:16EDGARStatement of Changes in Beneficial Ownership (4)
04/12/201813:16EDGARStatement of Changes in Beneficial Ownership (4)
04/12/201813:15EDGARStatement of Changes in Beneficial Ownership (4)
02/12/201821:45BWPfizer Presents Positive 26-Week Data For PF-05280586, A..
30/11/201816:00BWPfizer Reaches a Global Agreement with AbbVie
27/11/201821:01BWPfizer Receives Six Months Pediatric Exclusivity for LYRICA®..
26/11/201810:15DJFRBig Pharma offre un remède contre le blues du marché..
21/11/201819:49DJNFDA Approves Pfizer's Daurismo for Patients With Acute..
21/11/201819:40BWU.S. FDA Approves DAURISMO™ (glasdegib) for Adult Patients..
21/11/201816:00BWPfizer Invites Public to Listen to Webcast of Pfizer..
19/11/201814:20DJNMerck KGaA, Pfizer's Javelin Phase 3 Trial Missed Primary..
19/11/201813:12PRNUSMerck KGaA, Darmstadt, Germany, and Pfizer Provide Update on..
17/11/201809:02DJNPfizer to Raise Prices On 41 Drugs In January -- WSJ
17/11/201801:19DJNPfizer to Raise Prices on 41 Drugs -- Update
17/11/201800:42EDGARStatement of Changes in Beneficial Ownership (4)
17/11/201800:42EDGARStatement of Changes in Beneficial Ownership (4)
17/11/201800:42EDGARStatement of Changes in Beneficial Ownership (4)
17/11/201800:41EDGARStatement of Changes in Beneficial Ownership (4)
16/11/201822:00DJFRPfizer prévoit d'augmenter le prix de 41 médicaments -..
12/11/201819:13DJNCoty's Names New CEO -- Update
08/11/201822:47EDGARQuarterly Report (10-q)
06/11/201821:47EDGARStatement of Changes in Beneficial Ownership (4)
06/11/201814:30PRNUSNew Clinical Oncology Collaboration Between Nektar and..
02/11/201822:37DJNPfizer Says FDA Approves Lorbrena for Certain Lung Cancer..
02/11/201821:42BWU.S. FDA Approves LORBRENA® (lorlatinib) for..
02/11/201800:40EDGARStatement of Changes in Beneficial Ownership (4)
02/11/201800:40EDGARStatement of Changes in Beneficial Ownership (4)
02/11/201800:40EDGARStatement of Changes in Beneficial Ownership (4)
02/11/201800:40EDGARStatement of Changes in Beneficial Ownership (4)
01/11/201818:15DJFRPfizer étudie une vente de son pôle de soins pour femmes
01/11/201817:20DJNPfizer Weighs Options for Women's Health Line -Bloomberg
31/10/201808:02DJNPfizer Faces Pricing Pressures -- WSJ
30/10/201818:17DJNPfizer Narrows Guidance on Tougher Pricing -- Update
30/10/201815:16DJNU.S. Stocks Open Higher After Shaky Start to the Week
30/10/201814:13DJFRActualisé: Pfizer prévoit un revenu 2018 dans le bas de sa..
30/10/201813:52DJNGlobal Stocks Pause After Shaky Start to the Week
30/10/201813:44DJNCorrection to Pfizer Earnings Article
30/10/201813:41DJNPfizer Narrows Guidance on Tougher Pricing, Generic..
30/10/201813:40EDGARCurrent Report Filing (8-k)
30/10/201812:56DJNPfizer Narrows Guidance on Tougher Pricing, Generic..
30/10/201812:41DJFRPfizer publie un bénéfice meilleur que prévu mais un revenu..
30/10/201811:45BWPFIZER REPORTS THIRD-QUARTER 2018 RESULTS
30/10/201811:17DJFRUSA: prévisions des analystes pour les résultats attendus à..
29/10/201810:49DJFRNovartis et Pfizer concluent un accord de coopération dans..
29/10/201807:44DJNNovartis, Pfizer Collaborate on Drugs Targeting Complex..
29/10/201807:15BWPfizer Announces Clinical Development Agreement with..
24/10/201801:30DJNResults of Pfizer, Eli Lilly Tanezumab Study Show..
Voir d'autres actualités liées à cette action »
Dernières Valeurs Consultées
NYSE
PFE
Pfizer
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Conditions Générales

P: V: D:20181210 06:37:00